1. Järvinen K, Järvinen T, Urtti A. Ocular absorption following topical delivery. Adv Drug Deliv Rev. 1995;16:3–19.
2. Pal Kaur I, Kanwar M. Ocular preparations: the formulation approach. Drug Dev Ind Pharm. 2002;28:473–93.
3. Greaves J, Wilson C, Birmingham A. Assessment of the precorneal residence of an ophthalmic ointment in healthy subjects. Br J Clin Pharmacol. 1993;35:188.
4. FDA Orange Book. Url:
https://www.accessdata.fda.gov/scripts/cder/ob/
(accessed: 08.12.18).
5. Ueda CT, Shah VP, Derdzinski K, Ewing G, Flynn G, Maibach H, Marques M, Rytting H, Shaw S, Thakker K. Topical and transdermal drug products, Pharmacopeial Forum. 2009; pp 750–764.